Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Identifying isoniazid resistance markers to guide inclusion of high-dose isoniazid in tuberculosis treatment regimens

9 Jul 2020

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Infectious Diseases and Tuberculosis
Share to Mycobacterium research and diagnosis
Share to Tuberculosis Research and Epidemiology

Source

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Identifiers

PMID: 32653663
DOI: 10.1016/j.cmi.2020.07.004

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 22 Oct 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Identifying isoniazid resistance markers to guide inclusion of high-dose isoniazid in tuberculosis treatment regimensPMID 32653663Read ↗

Isoniazid-resistant tuberculosis: a cause for concern?Semantic proximity Read ↗

Drug resistance mechanisms and novel drug targets for tuberculosis therapySemantic proximity Read ↗

Co-resistance to isoniazid and second-line anti-tuberculosis drugs in isoniazid-resistant tuberculosis at a tertiary care hospital in Thailand.Semantic proximity Read ↗

Molecular tests for rapid detection of rifampicin and isoniazid resistance in Mycobacterium tuberculosis.Semantic proximity Read ↗

Genetic mutations associated with isoniazid resistance in Mycobacterium tuberculosis: a systematic review.Semantic proximity Read ↗

Characteristics and Treatment Outcomes of Isoniazid Mono-Resistant Tuberculosis: A Retrospective Study.Semantic proximity Read ↗

Correlating genetic mutations with isoniazid phenotypic levels of resistance in Mycobacterium tuberculosis isolates from patients with drug-resistant tuberculosis in a high burden setting.Semantic proximity Read ↗

A retrospective cohort study of isoniazid-resistant tuberculosis treatment outcomes and isoniazid resistance-associated mutations in eastern China from 2013 to 2018.Semantic proximity Read ↗

Prevalence of mutations in genes associated with isoniazid resistance in Mycobacterium tuberculosis isolates from re-treated smear-positive pulmonary tuberculosis patients: A meta-analysis.Semantic proximity Read ↗

Isoniazid resistance in <i>Mycobacterium tuberculosis</i> is a heterogeneous phenotype comprised of overlapping MIC distributions with different underlying resistance mechanismsSemantic proximity Read ↗

Molecular characterization of isoniazid-resistant clinical isolates of Mycobacterium tuberculosis from the USASemantic proximity Read ↗

Pharmacogenomics and mutation informatics: correlation of NAT2 mutations and isoniazid acetylation rate.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.